THE CLINICAL-SIGNIFICANCE OF INFECTIONS WITH CYTOMEGALOVIRUS STRAINS RESISTANT TO ANTIVIRAL DRUGS

被引:3
作者
BALFOUR, HH [1 ]
机构
[1] UNIV MINNESOTA,HLTH SCI CTR,DEPT PEDIAT,MINNEAPOLIS,MN 55455
来源
RESEARCH IN VIROLOGY | 1992年 / 143卷 / 03期
关键词
AIDS; TRANSPLANTATION; ANTIVIRAL DRUG; CMV; RESISTANCE; T-CELL DEPLETION;
D O I
10.1016/S0923-2516(06)80108-1
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
[No abstract available]
引用
收藏
页码:219 / 221
页数:3
相关论文
共 19 条
[1]   CYTOMEGALO-VIRUS - TROLL OF TRANSPLANTATION [J].
BALFOUR, HH .
ARCHIVES OF INTERNAL MEDICINE, 1979, 139 (03) :279-280
[2]   A RANDOMIZED, PLACEBO-CONTROLLED TRIAL OF ORAL ACYCLOVIR FOR THE PREVENTION OF CYTOMEGALO-VIRUS DISEASE IN RECIPIENTS OF RENAL-ALLOGRAFTS [J].
BALFOUR, HH ;
CHACE, BA ;
STAPLETON, JT ;
SIMMONS, RL ;
FRYD, DS .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 320 (21) :1381-1387
[3]  
BALFOUR HH, 1990, REV INFECT DIS, V12, pS849
[4]   A HUMAN CYTOMEGALOVIRUS MUTANT RESISTANT TO THE NUCLEOSIDE ANALOG 9-([2-HYDROXY-1-(HYDROXYMETHYL)ETHOXY]METHYL)GUANINE (BW B759U) INDUCES REDUCED LEVELS OF BW B759U TRIPHOSPHATE [J].
BIRON, KK ;
FYFE, JA ;
STANAT, SC ;
LESLIE, LK ;
SORRELL, JB ;
LAMBE, CU ;
COEN, DM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (22) :8769-8773
[5]  
DROBYSKI WR, 1991, TRANSPLANTATION, V52, P155
[6]   CYTOMEGALO-VIRUS PNEUMONIA AFTER BONE-MARROW TRANSPLANTATION SUCCESSFULLY TREATED WITH THE COMBINATION OF GANCICLOVIR AND HIGH-DOSE INTRAVENOUS IMMUNE GLOBULIN [J].
EMANUEL, D ;
CUNNINGHAM, I ;
JULESELYSEE, K ;
BROCHSTEIN, JA ;
KERNAN, NA ;
LAVER, J ;
STOVER, D ;
WHITE, DA ;
FELS, A ;
POLSKY, B ;
CASTROMALASPINA, H ;
PEPPARD, JR ;
BARTUS, P ;
HAMMERLING, U ;
OREILLY, RJ .
ANNALS OF INTERNAL MEDICINE, 1988, 109 (10) :777-782
[7]   GANCICLOVIR TREATMENT OF CYTOMEGALOVIRUS DISEASE IN TRANSPLANT RECIPIENTS AND OTHER IMMUNOCOMPROMISED HOSTS [J].
ERICE, A ;
JORDAN, C ;
CHACE, BA ;
FLETCHER, C ;
CHINNOCK, BJ ;
BALFOUR, HH .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1987, 257 (22) :3082-3087
[8]   PROGRESSIVE DISEASE DUE TO GANCICLOVIR-RESISTANT CYTOMEGALO-VIRUS IN IMMUNOCOMPROMISED PATIENTS [J].
ERICE, A ;
CHOU, S ;
BIRON, KK ;
STANAT, SC ;
BALFOUR, HH ;
JORDAN, MC .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 320 (05) :289-293
[9]   ACYCLOVIR-RESISTANT HERPES-SIMPLEX VIRUS-INFECTIONS IN PATIENTS WITH THE ACQUIRED IMMUNODEFICIENCY SYNDROME [J].
ERLICH, KS ;
MILLS, J ;
CHATIS, P ;
MERTZ, GJ ;
BUSCH, DF ;
FOLLANSBEE, SE ;
GRANT, RM ;
CRUMPACKER, CS .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 320 (05) :293-296
[10]   EARLY TREATMENT WITH GANCICLOVIR TO PREVENT CYTOMEGALOVIRUS DISEASE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION [J].
GOODRICH, JM ;
MORI, M ;
GLEAVES, CA ;
DUMOND, C ;
CAYS, M ;
EBELING, DF ;
BUHLES, WC ;
DEARMOND, B ;
MEYERS, JD .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 325 (23) :1601-1607